ID   KTOSA5
AC   CVCL_GY93
DR   Wikidata; Q54900665
RX   PubMed=24416158;
RX   PubMed=25190452;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, right hindlimb; UBERON=UBERON_0003464.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
RX   PubMed=24416158; DOI=10.1371/journal.pone.0083144; PMCID=PMC3885401;
RA   Pang L.Y., Gatenby E.L., Kamida A., Whitelaw C.B.A., Hupp T.R.,
RA   Argyle D.J.;
RT   "Global gene expression analysis of canine osteosarcoma stem cells
RT   reveals a novel role for COX-2 in tumour initiation.";
RL   PLoS ONE 9:e83144.1-e83144.13(2014).
//
RX   PubMed=25190452; DOI=10.1186/s12917-014-0184-9; PMCID=PMC4172958;
RA   Pang L.Y., Argyle S.A., Kamida A., Morrison K.O., Argyle D.J.;
RT   "The long-acting COX-2 inhibitor mavacoxib (Trocoxil TM) has
RT   anti-proliferative and pro-apoptotic effects on canine cancer cell
RT   lines and cancer stem cells in vitro.";
RL   BMC Vet. Res. 10:184.1-184.11(2014).
//